If a patient is experiencing side effects, dose escalation should be slower, and if severe, the dose should be reduced back to the dose that was tolerated
Source: CMS Medicare GLP-1 Bridge Program At a Glance: The Quick Facts IMPORTANT: Check This First This program is designed ONLY for weight loss
Munoz-Fernandez MA, Pimentel-Muinos FX, Alonso MA, Campanero M, Sanchez-Madrid F, Silva A, et al
Outcomes were assessed from 1 day postindex and continued up to 6 years postablation (2190 days)
SLU-PP-332 distribution The distribution pattern of SLU-PP-332 is characterized by: Rapid and extensive distribution to target tissues High volume of distribution, indicating good penetration into various body compartments Potential for crossing the blood-brain barrier, expanding its therapeutic potential These distribution characteristics may contribute to the versatility of SLU-PP-332 in treating various conditions